Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

The combination of durvalumab and platinum-based chemotherapy, followed by maintenance therapy with either durvalumab plus olaparib or durvalumab alone, elicited a statistically significant and...

A telephone and web-based weight loss intervention was successful in helping patients with breast cancer who were overweight or obese lose weight—which can ultimately...

  • 1662896686753013762 Profile photo of Madelyn

    A telephone and web-based weight loss intervention was successful in helping patients w/ breast cancer who were overweight or obese lose weight—which can ultimately lead to improved outcomes. #oncology #bcsm https://t.co/EEV4AYmvx9 - view on twitter

As longer-term data read out for established regimens in urothelial cancer and up-and-coming therapeutics inch toward approval, optimizing treatment approaches relies on buy-in from...

James Harding, MD, discusses the rationale for targeting FGFR2 in patients with cholangiocarcinoma and biliary tract...

The National Institute for Health and Care Excellence has recommended the combination of pembrolizumab and lenvatinib for use in previously treated patients with advanced...

The combination of durvalumab and platinum-based chemotherapy, followed by maintenance therapy with either durvalumab plus olaparib or durvalumab alone, elicited a statistically significant and...

CLDN18.2 has become a promising target for the treatment of patients with digestive malignancies, such as gastric cancer, gastroesophageal junction cancer, esophageal cancer, and...

The National Institute for Health and Care Excellence has recommended the combination of pembrolizumab and lenvatinib for use in previously treated patients with advanced...

  • 1661582914650292228 Profile photo of Madelyn

    The NICE has recommended pembrolizumab & lenvatinib for use in previously treated pts w/ advanced or recurrent endometrial cancer whose cancer has progressed on or after platinum-based chemotherapy & who cannot have curative surgery or radiotherapy #gyncsm https://t.co/fmM1GDKU3j - view on twitter

The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended the approval of nivolumab as neoadjuvant therapy in combination with platinum-based...

The National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology have been revised to include ropeginterferon alfa-2b-njft as a preferred treatment option for patients...

  • 1662700364842389504 Profile photo of Madelyn

    The NCCN Clinical Practice Guidelines in Oncology have been revised to include ropeginterferon alfa-2b-njft as a preferred treatment option for patients with high- and low-risk polycythemia vera, irrespective of treatment history. #mpnsm #oncology https://t.co/lsOuLHaKaV - view on twitter